Translational findings on brain-derived neurotrophic factor and anxiety: Contributions from basic research to clinical practice

Neuropsychobiology

Volumn 68, Issue 3, 2013, Pages 129-138

  Da Silveira Da Luz, Anna Claudia Domingos ^a,b   Dias, Pereira Gisele ^a,b,d   Do Nascimento Bevilaqua, Mário Cesar ^a,b,c   Cocks, Graham ^d   Gardino, Patricia Franca ^a   Thuret, Sandrine ^d   Nardi, Antonio Egidio ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b National Institute for Translational Medicine INCT TM CNPq   (Brazil)

^c Universidade Castelo Branco   (Brazil)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anxiety; Brain derived neurotrophic factor; Humans; Mouse model; Translational research; Val66Met polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ANXIETY DISORDER; BASIC RESEARCH; BEHAVIOR CHANGE; CLINICAL PRACTICE; DNA POLYMORPHISM; HUMAN; LEARNING; MEDICAL RESEARCH; MEMORY; NERVE CELL; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; PHYSIOLOGICAL PROCESS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; ANXIETY; COGNITION; GENETIC POLYMORPHISM; HIPPOCAMPUS; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; SYNAPTIC TRANSMISSION;

ANIMALS; ANXIETY; BRAIN-DERIVED NEUROTROPHIC FACTOR; HUMANS; MEMORY; MICE; POLYMORPHISM, GENETIC; RATS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84888237584     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000353269     Document Type: Review

References (96)

1. Gross C, Hen R: Genetic and environmental factors interact to influence anxiety (review). Neurotox Res 2004; 6: 493-501.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 2000.
3. Anagnostaras SG, Maren S, Sage JR, Goodrich S, Fanselow MS: Scopolamine and Pavlovian fear conditioning in rats: dose-effect analysis. Neuropsychopharmacology 1999;21:731-744, erratum 2000; 22: 332.
4. Minelli A, Bonvicini C, Scassellati C, Sartori R, Gennarelli M: The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. BMC Psychiatry 2011; 11: 50.
5. Murrough JW, Czermak C, Henry S, Nabulsi N, Gallezot JD, Gueorguieva R, Planeta-Wilson B, Krystal JH, Neumaier JF, Huang Y, Ding YS, Carson RE, Neumeister A: The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding. Arch Gen Psychiatry 2011; 68: 892-900.
6. Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, Pitman RK: Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci 2002; 5: 1242-1247.
7. Babygirija R, Yoshimoto S, Gribovskaja-Rupp I, Bülbül M, Ludwig K, Takahashi T: Social interaction attenuates stress responses following chronic stress in maternally separated rats. Brain Res 2012; 1469: 54-62.
8. Françolin-Silva AL, da Silva Hernandes A, Fukuda MT, Valadares CT, Almeida SS: Anxiolytic-like effects of short-term postnatal protein malnutrition in the elevated plusmaze test. Behav Brain Res 2006; 173: 310-314.
9. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R: Serotonin 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002; 416: 396-400.
10. Gross C, Hen R: The developmental origins of anxiety (review). Nat Rev Neurosci 2004; 5: 545-552.
11. Cotman CW, Berchtold NC: Exercise: a behavioral intervention to enhance brain health and plasticity (review). Trends Neurosci 2002; 25: 295-301.
12. Monfils MH, Cowansage KK, LeDoux JE: Brain-derived neurotrophic factor: linking fear learning to memory consolidation. Mol Pharmacol 2007; 72: 235-237.
13. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S: Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 2005; 255: 381-386.
14. Berry A, Bellisario V, Capoccia S, Tirassa P, Calza A, Alleva E, Cirulli F: Social deprivation stress is a triggering factor for the emergence of anxiety-and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice. Psychoneuroendocrinology 2012; 37: 762-772.
15. Soliman F, Glatt CE, Bath KG, Levita L, Jones RM, Pattwell SS, Jing D, Tottenham N, Amso D, Somerville LH, Voss HU, Glover G, Ballon DJ, Liston C, Teslovich T, Van Kempen T, Lee FS, Casey BJ: A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 2010; 327: 863-866.
16. Lonsdorf TB, Weike AI, Golkar A, Schalling M, Hamm AO, Ohman A: Amygdala-dependent fear conditioning in humans is modulated by the BDNFval66met polymorphism. Behav Neurosci 2010; 124: 9-15.
17. Barde YA, Edgar D, Thoenen H: Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982; 1: 549-553.
18. Cunha C, Brambilla R, Thomas KL: A simple role for BDNF in learning and memory? Front Mol Neurosci 2010; 3: 1.
19. Vaynman S, Ying Z, Gomez-Pinilla F: Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 2004; 20: 2580-2590.
20. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ: Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007; 12: 656-670.
21. Choi DC, Maguschak KA, Ye K, Jang SW, Myers KM, Ressler KJ: Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc Natl Acad Sci USA 2010; 107: 2675-2680.
22. Zhou XF, Song XY, Zhong JH, Barati S, Zhou FH, Johnson SM: Distribution and localization of pro-brain-derived neurotrophic factor-like immunoreactivity in the peripheral and central nervous system of the adult rat. J Neurochem 2004; 91: 704-715.
23. Callaghan CK, Kelly AM: Differential BDNF signaling in dentate gyrus and perirhinal cortex during consolidation of recognition memory in the rat. Hippocampus 2012; 22: 2127-2135.
24. Daftary SS, Calderon G, Rios M: Essential role of brain-derived neurotrophic factor in the regulation of serotonin transmission in the basolateral amygdala. Neuroscience 2012; 224: 125-134.
25. Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD: From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning (review). Learn Mem 2002; 9: 224-237.
26. Lu Y, Christian K, Lu B: BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory (review)? Neurobiol Learn Mem 2008; 89: 312-323.
27. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ: Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007; 12: 656-670.
28. Kafitz KW, Rose CR, Thoenen H, Konnerth A: Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 1999; 401: 918-921.
29. Rose CR, Blum R, Kafitz KW, Kovalchuk Y, Konnerth A: From modulator to mediator: rapid effects of BDNF on ion channels (review). Bioessays 2004; 26: 1185-1194.
30. Kovalchuk Y, Hanse E, Kafitz KW, Konnerth A: Postsynaptic induction of BDNF-mediated long-term potentiation. Science 2002; 295: 1729-1734.
31. Kang H, Schuman EM: Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995; 267: 1658-1662.
32. Mattson MP: Glutamate and neurotrophic factors in neuronal plasticity and disease (review). Ann NY Acad Sci 2008; 1144: 97-112.
33. Seil FJ: TrkB receptor signaling and activitydependent inhibitory synaptogenesis (review). Histol Histopathol 2003; 18: 635-646.
34. Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S: Brain-derived neurotrophic factor and the development of structural neuronal connectivity (review). Dev Neurobiol 2010; 70: 271-288.
35. Zagrebelsky M, Holz A, Dechant G, Barde YA, Bonhoeffer T, Korte M: The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J Neurosci 2005; 25: 9989-9999.
36. Hennigan A, O'Callaghan RM, Kelly AM: Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem Soc Trans 2007;35(Pt 2): 424-427.
37. Alcántara S, Frisén J, del Río JA, Soriano E, Barbacid M, Silos-Santiago I: TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J Neurosci 1997; 17: 3623-3633.
38. Choi SH, Li Y, Parada LF, Sisodia SS: Regulation of hippocampal progenitor cell survival, proliferation and dendritic development by BDNF. Mol Neurodegener 2009; 4: 52.
39. Vigers AJ, Amin DS, Talley-Farnham T, Gorski JA, Xu B, Jones KR: Sustained expression of brain-derived neurotrophic factor is required for maintenance of dendritic spines and normal behavior. Neuroscience 2012; 212: 1-18.
40. Rattiner LM, Davis M, Ressler KJ: Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learn Mem 2004; 11: 727-731.
41. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME: CREB: a major mediator of neuronal neurotrophin responses. Neuron 1997; 19: 1031-1047.
42. Haapasalo A, Sipola I, Larsson K, Akerman KE, Stoilov P, Stamm S, Wong G, Castren E: Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRKB isoforms. J Biol Chem 2002; 277: 43160-43167.
43. Canossa M, Griesbeck O, Berninger B, Campana G, Kolbeck R, Thoenen H: Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity. Proc Natl Acad Sci USA 1997; 94: 13279-13286.
44. Cheng PL, Song AH, Wong YH, Wang S, Zhang X, Poo MM: Self-amplifying autocrine actions of BDNF in axon development. Proc Natl Acad Sci USA 2011; 108: 18430-18435.
45. Frank L, Ventimiglia R, Anderson K, Lindsay RM, Rudge JS: BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons. Eur J Neurosci 1996; 8: 1220-1230.
46. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
47. Shimizu E, Hashimoto K, Iyo M: Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 2004; 126B:122-123.
48. Pivac N, Kim B, Nedić G, Joo YH, Kozarić-Kovacić D, Hong JP, Muck-Seler D: Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants. Croat Med J 2009; 50: 43-48.
49. Stern AJ, Savostyanova AA, Goldman A, Barnett AS, van der Veen JW, Callicott JH, Mattay VS, Weinberger DR, Marenco S: Impact of the brain-derived neurotrophic factor Val66 Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biol Psychiatry 2008; 64: 856-862.
50. Klein AB, Trajkovska V, Erritzoe D, Haugbol S, Madsen J, Baaré W, Aznar S, Knudsen GM: Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels. J Cereb Blood Flow Metab 2010; 30:e1-e7.
51. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK: BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 2006; 59: 812-815.
52. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR: The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1652-1655.
53. Sublette ME, Baca-Garcia E, Parsey RV, Oquendo MA, Rodrigues SM, Galfalvy H, Huang YY, Arango V, Mann JJ: Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1652-1655.
54. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR: Brain-derived neurotrophic factor val-66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003; 23: 6690-6694.
55. Tsai SJ, Hong CJ, Yu YW, Chen TJ: Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 2004; 49: 13-16.
56. Hopkins ME, Davis FC, Vantieghem MR, Whalen PJ, Bucci DJ: Differential effects of acute and regular physical exercise on cognition and affect. Neuroscience 2012; 215: 59-68.
57. Xu C, Wang Z, Fan M, Liu B, Song M, Zhen X, Jiang T, Alzheimer's Disease Neuroimaging Initiative: Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease. Neuroreport 2010; 21: 802-807.
58. Pivac N, Nikolac M, Nedic G, Mustapic M, Borovecki F, Hajnsek S, Presecki P, Pavlovic M, Mimica N, Muck Seler D: Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 356-362.
59. Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, Miranda D, Lobaugh NJ, Mulsant BH, Pollock BG, Kennedy JL: The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch Gen Psychiatry 2011; 68: 198-206.
60. Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, Ashtari M, Napolitano B, Bilder RM, Kane JM, Goldman D, Malhotra AK: Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 2005; 10: 631-636.
61. Whalley HC, Baig BJ, Hall J, Job DE, McIntosh AM, Cunningham-Owens DG, Johnstone EC, Lawrie SM: Effects of the BDNF val-66met polymorphism on prefrontal brain function in a population at high genetic risk of schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:1474-1482.
62. Aureli A, Del Beato T, Sebastiani P, Marimpietri A, Melillo CV, Sechi E, Di Loreto S: Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms. Int J Immunopathol Pharmacol 2010; 23: 873-880.
63. Hosang GM, Uher R, Keers R, Cohen-Woods S, Craig I, Korszun A, Perry J, Tozzi F, Muglia P, McGuffin P, Farmer AE: Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J Affect Disord 2010; 125: 345-349.
64. Dwivedi Y: Brain-derived neurotrophic factor and suicide pathogenesis (review). Ann Med 2010; 42: 87-96.
65. Guerini FR, Beghi E, Riboldazzi G, Zangaglia R, Pianezzola C, Bono G, Casali C, Di Lorenzo C, Agliardi C, Nappi G, Clerici M, Martignoni E: BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease. Eur J Neurol 2009; 16: 1240-1245.
66. Vinberg M, Trajkovska V, Bennike B, Knorr U, Knudsen GM, Kessing LV: The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol. Psychoneuroendocrinology 2009; 34: 1380-1389.
67. Wojnar M, Brower KJ, Strobbe S, Ilgen M, Matsumoto H, Nowosad I, Sliwerska E, Burmeister M: Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin Exp Res 2009; 33: 693-702.
68. Hou H, Qing Z, Jia S, Zhang X, Hu S, Hu J: Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset for heroin abuse in males. Brain Res 2010; 1353: 245-248.
69. Gatt JM, Nemeroff CB, Schofield PR, Paul RH, Clark CR, Gordon E, Williams LM: Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66. to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol Psychiatry 2010; 68: 818-824.
70. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, Lee FS: Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activitydependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004; 24: 4401-4411.
71. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS: Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006; 314: 140-143.
72. Hashimoto K: BDNF variant linked to anxiety-related behaviors (review). Bioessays 2007; 29: 116-119.
73. Bath KG, Jing DQ, Dincheva I, Neeb CC, Pattwell SS, Chao MV, Lee FS, Ninan I: BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity. Neuropsychopharmacology 2012; 37: 1297-1304.
74. Canteras NS, Resstel LB, Bertoglio LJ, Carobrez Ade P, Guimaraes FS: Neuroanatomy of anxiety (review). Curr Top Behav Neurosci 2010; 2: 77-96.
75. Yu H, Wang DD, Wang Y, Liu T, Lee FS, Chen ZY: Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J Neurosci 2012; 32: 4092-4101.
76. Colzato LS, Van der Does AJ, Kouwenhoven C, Elzinga BM, Hommel B: BDNF Val66Met polymorphism is associated with higher anticipatory cortisol stress response, anxiety, and alcohol consumption in healthy adults. Psychoneuroendocrinology 2011; 36: 1562-1569.
77. Dougherty LR, Klein DN, Congdon E, Canli T, Hayden EP: Interaction between 5-HTTLPR and BDNF Val66Met polymorphisms on HPA axis reactivity in preschoolers. Biol Psychol 2010; 83: 93-100.
78. Shalev I, Lerer E, Israel S, Uzefovsky F, Gritsenko I, Mankuta D, Ebstein RP, Kaitz M: BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology 2009; 34: 382-388.
79. Yu H, Wang Y, Pattwell S, Jing D, Liu T, Zhang Y, Bath KG, Lee FS, Chen ZY: Variant BDNF Val66Met polymorphism affects extinction of conditioned aversive memory. J Neurosci 2009; 29: 4056-4064.
80. Frielingsdorf H, Bath KG, Soliman F, Difede J, Casey BJ, Lee FS: Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder (review). Ann NY Acad Sci 2010; 1208: 150-157, erratum 2011; 1217: 207.
81. Chen ZY, Bath K, McEwen B, Hempstead B, Lee F: Impact of genetic variant BDNF (Val66 Met) on brain structure and function (review). Novartis Found Symp 2008; 289: 180-188, discussion pp 188-195.
82. Lam P, Cheng CY, Hong CJ, Tsai SJ: Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology 2004; 49: 178-181.
83. Shimizu E, Hashimoto K, Koizumi H, Kobayashi K, Itoh K, Mitsumori M, Ohgake S, Okamura N, Koike K, Matsuzawa D, Zhang L, Kumakiri C, Nakazato M, Komatsu N, Iyo M: No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 708-712.
84. Wendland JR, Kruse MR, Cromer KR, Murphy DL: A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology 2007; 32: 2543-2551.
85. Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, Hemmings SM, Carey PD, Stein DJ, Sondervan D, Boer JA, van Balkom AJ, Polman A, Heutink P: The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD). Am J Med Genet B Neuropsychiatr Genet 2009; 150B:1050-1062.
86. da Rocha FF, Malloy-Diniz L, Lage NV, Corrêa H: The relationship between the Met allele of the BDNF Val66Met polymorphism and impairments in decision making under ambiguity in patients with obsessive-compulsive disorder. Genes Brain Behav 2011; 10: 523-529.
87. Fullana MA, Alonso P, Gratacòs M, Jaurrieta N, Jiménez-Murcia S, Segalas C, Real E, Estivill X, Menchón JM: Variation in the BDNF Val66 Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder. Eur Psychiatry 2012; 27: 386-390.
88. Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, Price LH, Southwick S, Yang BZ, Rasmussen A, Gelernter J: Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet 2006; 141B:387-393.
89. Valente NL, Vallada H, Cordeiro Q, Miguita K, Bressan RA, Andreoli SB, Mari JJ, Mello MF: Candidate-gene approach in posttraumatic stress disorder after urban violence: association analysis of the genes encoding serotonin transporter, dopamine transporter, and BDNF. J Mol Neurosci 2011; 44: 59-67.
90. Wichers M, Kenis G, Jacobs N, Myin-Germeys I, Schruers K, Mengelers R, Delespaul P, Derom C, Vlietinck R, van Os J: The psychology of psychiatric genetics: evidence that positive emotions in females moderate genetic sensitivity to social stress associated with the BDNF Val-sup-6-sup-6Met polymorphism. J Abnorm Psychol 2008; 117: 699-704.
91. Xie B, Wang B, Suo P, Kou C, Wang J, Meng X, Cheng L, Ma X, Yu Y: Genetic association between BDNF gene polymorphisms and phobic disorders: a case-control study among mainland Han Chinese. J Affect Disord 2011; 132: 239-242.
92. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, Harris CR, Marini AM, Enoch MA, Lipsky RH: BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005; 30: 1353-1361.
93. Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM: Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 2009; 14: 681-695.
94. Tocchetto A, Salum GA, Blaya C, Teche S, Isolan L, Bortoluzzi A, Rebelo E Silva R, Becker JA, Bianchin MM, Rohde LA, Leistner-Segal S, Manfro GG: Evidence of association between Val66Met polymorphism at BDNF gene and anxiety disorders in a community sample of children and adolescents. Neurosci Lett 2011; 502: 197-200.
95. Hünnerkopf R, Strobel A, Gutknecht L, Brocke B, Lesch KP: Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 2007; 32: 2552-2560.
96. Arias B, Aguilera M, Moya J, Sáiz PA, Villa H, Ibáñez MI, García-Portillo MP, Bobes J, Ortet G, Fañanás L: The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety-related traits. Acta Psychiatr Scand 2012; 125: 194-202.